Skip to main content
Signal8

Kilroy Conor

SEC insider (Form 3/4/5 filer). CIK 0001808510. Officer at Aura Biosciences, Inc. (AURA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in BOSTON, MA.

Companies Kilroy Conor has filed insider reports for

  • Aura Biosciences, Inc. (AURA): Officer, See Remarks
Kilroy Conor profile photo

Kilroy Conor

CIK: 0001808510

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aura Biosciences, Inc. logo
AURA

Aura Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Jul 1, 2026
    Award
    Direct
    14.9K shares-
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Apr 16, 2026
    Sale
    Direct
    11.7K shares at avg. $7.02$82K
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Mar 2, 2026
    Award
    Direct
    62.3K shares-
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Feb 17, 2026
    Sale
    Direct
    12.1K shares at avg. $5.05$61K
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Apr 16, 2025
    Sale
    Direct
    7.2K shares at avg. $5.49$39K
  • Aura Biosciences, Inc. logo
    AURA

    Aura Biosciences, Inc.

    Feb 3, 2025
    Award
    Direct
    90.5K shares-

1-6 of 6